Regulation of rDNA transcription in response to growth factors, nutrients and energy

Gene

Volumn 556, Issue 1, 2015, Pages 27-34

  Kusnadi, Eric P ^a,b   Hannan, Katherine M ^a,b   Hicks, Rodney J ^a,b   Hannan, Ross D ^a,b,c,d   Pearson, Richard B ^a,b,c   Kang, Jian ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Amino acids; Energy; Growth factors; MTORC1; Nutrients; RDNA transcription

Indexed keywords

DNA DIRECTED RNA POLYMERASE; GROWTH FACTOR; RIBOSOME DNA; RIBOSOME RNA; ADENOSINE TRIPHOSPHATE; AMINO ACID; SIGNAL PEPTIDE;

BIOGENESIS; ENERGY; ENZYME ACTIVITY; HUMAN; METABOLIC REGULATION; MODULATION; NEOPLASM; NONHUMAN; NUTRIENT; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; REVIEW; RIBOSOME; RNA SYNTHESIS; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; ENERGY METABOLISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEOPLASMS; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; AMINO ACIDS; ANIMALS; DNA, RIBOSOMAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; RIBOSOMES; RNA POLYMERASE I; RNA, RIBOSOMAL; TRANSCRIPTION, GENETIC;

EID: 84922662987     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.11.010     Document Type: Review

References (118)

1. Altman B.J., Dang C.V. Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J. 2012, 279:2598-2609.
2. Arabi A., Wu S., Ridderstrale K., Bierhoff H., Shiue C., Fatyol K., Fahlen S., Hydbring P., Soderberg O., Grummt I., Larsson L.G., Wright A.P. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol. 2005, 7:303-310.
3. Bar-Peled L., Schweitzer L.D., Zoncu R., Sabatini D.M. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208.
4. Bauchart-Thevret C., Cui L., Wu G., Burrin D.G. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E899-E909.
5. Butler E.B., Zhao Y., Muñoz-Pinedo C., Lu J., Tan M. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Res. 2013, 73:2709-2717.
6. Bywater M.J., Poortinga G., Sanij E., Hein N., Peck A., Cullinane C., Wall M., Cluse L., Drygin D., Anderes K., Huser N., Proffitt C., Bliesath J., Haddach M., Schwaebe M.K., Ryckman D.M., Rice W.G., Schmitt C., Lowe S.W., Johnstone R.W., Pearson R.B., McArthur G.A., Hannan R.D. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22:51-65.
7. Bywater M.J., Pearson R.B., McArthur G.A., Hannan R.D. Dysregulation of the basal RNA polymerase transcription apparatus in cancer. Nat. Rev. Cancer 2013, 13:299-314.
8. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
9. Campbell L.E., Wang X., Proud C.G. Nutrients differentially regulate multiple translation factors and their control by insulin. Biochem. J. 1999, 344(Pt 2):433-441.
10. Chan J.C., Hannan K.M., Riddell K., Ng P.Y., Peck A., Lee R.S., Hung S., Astle M.V., Bywater M., Wall M. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer. Sci. Signal. 2011, 4:ra56.
11. Chauvin C., Koka V., Nouschi A., Mieulet V., Hoareau-Aveilla C., Dreazen A., Cagnard N., Carpentier W., Kiss T., Meyuhas O. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene 2013, 33:474-483.
12. Chen J.-Q., Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2012, 1826:370-384.
13. Csibi A., Fendt S.M., Li C., Poulogiannis G., Choo A.Y., Chapski D.J., Jeong S.M., Dempsey J.M., Parkhitko A., Morrison T., Henske E.P., Haigis M.C., Cantley L.C., Stephanopoulos G., Yu J., Blenis J. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 2013, 153:840-854.
14. Csibi A., Lee G., Yoon S.O., Tong H., Ilter D., Elia I., Fendt S.M., Roberts T.M., Blenis J. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation. Curr. Biol. 2014, 24:2274-2280.
15. Daye D., Wellen K.E. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin. Cell Dev. Biol. 2012, 23:362-369.
16. De Benedetti A., Joshi B., Graff J., Zimmer S. CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol. Cell. Differ. 1994, 2:347-371.
17. Derenzini M., Montanaro L., Treré D. What the nucleolus says to a tumour pathologist. Histopathology 2009, 54:753-762.
18. Devlin J.R., Hannan K.M., Ng P.Y., Bywater M.J., Shortt J., Cullinane C., McArthur G.A., Johnstone R.W., Hannan R.D., Pearson R.B. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo. FEBS J. 2013, 280:5307-5316.
19. Dibble C.C., Elis W., Menon S., Qin W., Klekota J., Asara J.M., Finan P.M., Kwiatkowski D.J., Murphy L.O., Manning B.D. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 2012, 47:535-546.
20. Diesch J., Hannan R., Sanij E. Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease. Cell Biosci. 2014, 4:43.
21. Drygin D., Lin A., Bliesath J., Ho C.B., O'Brien S.E., Proffitt C., Omori M., Haddach M., Schwaebe M.K., Siddiqui-Jain A. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 2011, 71:1418-1430.
22. Drygin D., O'Brien S.E., Hannan R.D., McArthur G.A., Von Hoff D.D. Targeting the nucleolus for cancer-specific activation of p53. Drug Discov. Today 2014, 19:259-265.
23. Durán R.V., Oppliger W., Robitaille A.M., Heiserich L., Skendaj R., Gottlieb E., Hall M.N. Glutaminolysis activates Rag-mTORC1 signaling. Mol. Cell 2012, 47:349-358.
24. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin. Cancer Biol. 2005, 15:254-266.
25. Ganapathy-Kanniappan S., Kunjithapatham R., Geschwind J.-F. Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma. Oncotarget 2012, 3:940.
26. Gao P., Tchernyshyov I., Chang T.-C., Lee Y.-S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
27. Grandori C., Gomez-Roman N., Felton-Edkins Z.A., Ngouenet C., Galloway D.A., Eisenman R.N., White R.J. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 2005, 7:311-318.
28. Grewal S.S., Li L., Orian A., Eisenman R.N., Edgar B.A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat. Cell Biol. 2005, 7:295-302.
29. Grummt I. Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev. 2003, 17:1691-1702.
30. Grummt I. Wisely chosen paths-regulation of rRNA synthesis. FEBS J. 2010, 277:4626-4639.
31. Grummt I., Smith V.A., Grummt F. Amino acid starvation affects the initiation frequency of nucleolar RNA polymerase. Cell 1976, 7:439-445.
32. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
33. Han J.M., Jeong S.J., Park M.C., Kim G., Kwon N.H., Kim H.K., Ha S.H., Ryu S.H., Kim S. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149:410-424.
34. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
35. Hannan K.M., Brandenburger Y., Jenkins A., Sharkey K., Cavanaugh A., Rothblum L., Moss T., Poortinga G., McArthur G.A., Pearson R.B. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol. Cell. Biol. 2003, 23:8862-8877.
36. Hannan K.M., Sanij E., Hein N., Hannan R.D., Pearson R.B. Signaling to the ribosome in cancer-it is more than just mTORC1. IUBMB Life 2011, 63:79-85.
37. Hannan R.D., Drygin D., Pearson R.B. Targeting RNA polymerase I transcription and the nucleolus for cancer therapy. Expert Opin. Ther. Targets 2013, 17:873-878.
38. Hara K., Yonezawa K., Weng Q.-P., Kozlowski M.T., Belham C., Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 1998, 273:14484-14494.
39. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., Hardie D.G. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
40. Hein N., Hannan K.M., George A.J., Sanij E., Hannan R.D. The nucleolus: an emerging target for cancer therapy. Trends Mol. Med. 2013, 19:643-654.
41. Henderson A.S., Warburton D., Atwood K.C. Location of ribosomal DNA in the human chromosome complement. Proc. Natl. Acad. Sci. U. S. A. 1972, 69:3394-3398.
42. Hoppe S., Bierhoff H., Cado I., Weber A., Tiebe M., Grummt I., Voit R. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17781-17786.
43. Hořejší Z., Takai H., Adelman C.A., Collis S.J., Flynn H., Maslen S., Skehel J.M., de Lange T., Boulton S.J. CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability. Mol. Cell 2010, 39:839-850.
44. Howell J.J., Manning B.D. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol. Metab. 2011, 22:94-102.
45. Iadevaia V., Liu R., Proud C.G. mTORC1 signaling controls multiple steps in ribosome biogenesis. Semin. Cell Dev. Biol. 2014, 10.1016/j.semcdb.2014.08.004.
46. Inoki K., Li Y., Xu T., Guan K.-L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003, 17:1829-1834.
47. Inoki K., Zhu T., Guan K.-L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
48. Izumi N., Yamashita A., Iwamatsu A., Kurata R., Nakamura H., Saari B., Hirano H., Anderson P., Ohno S. AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function in nonsense-mediated mRNA decay. Sci. Signal. 2010, 3:ra27.
49. James M.J., Zomerdijk J.C. Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. J. Biol. Chem. 2004, 279:8911-8918.
50. Katt W.P., Cerione R.A. Glutaminase regulation in cancer cells: a druggable chain of events. Drug Discov. Today 2014, 19:450-457.
51. Kim S., Li Q., Dang C.V., Lee L.A. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc. Natl. Acad. Sci. 2000, 97:11198-11202.
52. Kim D.-H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
53. Kim S.G., Buel G.R., Blenis J. Nutrient regulation of the mTOR complex 1 signaling pathway. Mol. Cells 2013, 35:463-473.
54. Kim S.G., Hoffman G.R., Poulogiannis G., Buel G.R., Jang Y.J., Lee K.W., Kim B.-Y., Erikson R.L., Cantley L.C., Choo A.Y., Blenis J. Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. Mol. Cell 2013, 49:172-185.
55. Kleijn M., Proud C.G. Glucose and amino acids modulate translation factor activation by growth factors in PC12 cells. Biochem. J. 2000, 347:399-406.
56. 18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. J. Med. Chem. 2011, 54:406-410.
57. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012, 15:110-121.
58. Lizcano J.M., Göransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Mäkelä T.P., Hardie D.G. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23:833-843.
59. Long X., Ortiz-Vega S., Lin Y., Avruch J. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 2005, 280:23433-23436.
60. Mahajan P.B. Modulation of transcription of rRNA genes by rapamycin. Int. J. Immunopharmacol. 1994, 16:711-721.
61. Mayer C., Zhao J., Yuan X., Grummt I. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 2004, 18:423-434.
62. Moir R.D., Willis I.M. Regulation of Pol III transcription by nutrient and stress signaling pathways. Biochim. Biophys. Acta 2013, 1829:361-375.
63. Momcilovic M., Hong S.-P., Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 2006, 281:25336-25343.
64. Moss T., Langlois F., Gagnon-Kugler T., Stefanovsky V. A housekeeper with power of attorney: the rRNA genes in ribosome biogenesis. Cell. Mol. Life Sci. 2007, 64:29-49.
65. Murayama A., Ohmori K., Fujimura A., Minami H., Yasuzawa-Tanaka K., Kuroda T., Oie S., Daitoku H., Okuwaki M., Nagata K. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008, 133:627-639.
66. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., Yang H., Hild M., Kung C., Wilson C. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
67. Panse V.G., Johnson A.W. Maturation of eukaryotic ribosomes: acquisition of functionality. Trends Biochem. Sci. 2010, 35:260-266.
68. Parmenter T.J., Kleinschmidt M., Kinross K.M., Bond S.T., Li J., Kaadige M.R., Rao A., Sheppard K.E., Hugo W., Pupo G.M. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov. 2014, 4:423-433.
69. Peltonen K., Colis L., Liu H., Jaamaa S., Zhang Z., Af Hallstrom T., Moore H.M., Sirajuddin P., Laiho M. Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress. Mol. Cancer Ther. 2014, 10.1158/1535-7163.MCT-14-0256.
70. Peltonen K., Colis L., Liu H., Trivedi R., Moubarek M.S., Moore H.M., Bai B., Rudek M.A., Bieberich C.J., Laiho M. A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 2014, 25:77-90.
71. Poortinga G., Hannan K.M., Snelling H., Walkley C.R., Jenkins A., Sharkey K., Wall M., Brandenburger Y., Palatsides M., Pearson R.B. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J. 2004, 23:3325-3335.
72. Poortinga G., Wall M., Sanij E., Siwicki K., Ellul J., Brown D., Holloway T.P., Hannan R.D., McArthur G.A. c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation. Nucleic Acids Res. 2011, 39:3267-3281.
73. Poortinga G., Quinn L., Hannan R. Targeting RNA polymerase I to treat MYC-driven cancer. Oncogene 2014, 10.1038/onc.2014.13.
74. Pourdehnad M., Truitt M.L., Siddiqi I.N., Ducker G.S., Shokat K.M., Ruggero D. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:11988-11993.
75. Quin J.E., Devlin J.R., Cameron D., Hannan K.M., Pearson R.B., Hannan R.D. Targeting the nucleolus for cancer intervention. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2014, 1842:802-816.
76. Ruggero D., Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev. Cancer 2003, 3:179-192.
77. Russell J., Zomerdijk J.C. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem. Sci. 2005, 30:87-96.
78. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., Sabatini D.M. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496-1501.
79. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
80. Sanij E., Poortinga G., Sharkey K., Hung S., Holloway T.P., Quin J., Robb E., Wong L.H., Thomas W.G., Stefanovsky V., Moss T., Rothblum L.I., Hannan K.M., McArthur G.A., Pearson R.B., Hannan R.D. UBF levels determine the number of active ribosomal RNA genes in mammals. J. Cell Biol. 2008, 183:1259-1274.
81. Schmidt E.V. The role of c-myc in cellular growth control. Oncogene 1999, 18:2988-2996.
82. Schneider D.A. RNA polymerase I activity is regulated at multiple steps in the transcription cycle: recent insights into factors that influence transcription elongation. Gene 2012, 493:176-184.
83. Schulze A., Harris A.L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012, 491:364-373.
84. Sears R., Leone G., DeGregori J., Nevins J.R. Ras enhances Myc protein stability. Mol. Cell 1999, 3:169-179.
85. Sekiguchi T., Hirose E., Nakashima N., Ii M., Nishimoto T. Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. J. Biol. Chem. 2001, 276:7246-7257.
86. Shimobayashi M., Hall M.N. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell Biol. 2014, 15:155-162.
87. Shiue C.N., Berkson R.G., Wright A.P. c-Myc induces changes in higher order rDNA structure on stimulation of quiescent cells. Oncogene 2009, 28:1833-1842.
88. Smith E.M., Finn S.G., Tee A.R., Browne G.J., Proud C.G. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 2005, 280:18717-18727.
89. Stefanovsky V.Y., Moss T. The splice variants of UBF differentially regulate RNA polymerase I transcription elongation in response to ERK phosphorylation. Nucleic Acids Res. 2008, 36:5093-5101.
90. Stefanovsky V.Y., Pelletier G., Hannan R., Gagnon-Kugler T., Rothblum L.I., Moss T. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol. Cell 2001, 8:1063-1073.
91. Stefanovsky V., Langlois F., Gagnon-Kugler T., Rothblum L.I., Moss T. Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling. Mol. Cell 2006, 21:629-639.
92. Stefanovsky V.Y., Langlois F., Bazett-Jones D., Pelletier G., Moss T. ERK modulates DNA bending and enhancesome structure by phosphorylating HMG1-boxes 1 and 2 of the RNA polymerase I transcription factor UBF. Biochemistry 2006, 45:3626-3634.
93. Stults D.M., Killen M.W., Pierce H.H., Pierce A.J. Genomic architecture and inheritance of human ribosomal RNA gene clusters. Genome Res. 2008, 18:13-18.
94. Suzuki T., Bridges D., Nakada D., Skiniotis G., Morrison S.J., Lin J.D., Saltiel A.R., Inoki K. Inhibition of AMPK catabolic action by GSK3. Mol. Cell 2013, 50:407-419.
95. Takai H., Wang R.C., Takai K.K., Yang H., de Lange T. Tel2 regulates the stability of PI3K-related protein kinases. Cell 2007, 131:1248-1259.
96. Taylor P.M. Role of amino acid transporters in amino acid sensing. Am. J. Clin. Nutr. 2014, 99:223S-230S.
97. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 2003, 13:1259-1268.
98. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
99. Thorens B., Mueckler M. Glucose transporters in the 21st century. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E141-E145.
100. Uemura M., Zheng Q., Koh C., Nelson W., Yegnasubramanian S., De Marzo A. Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. Oncogene 2011, 31:1254-1263.
101. Wall M., Poortinga G., Hannan K.M., Pearson R.B., Hannan R.D., McArthur G.A. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood 2008, 112:2305-2317.
102. Wall M., Poortinga G., Stanley K.L., Lindemann R.K., Bots M., Chan C.J., Bywater M.J., Kinross K.M., Astle M.V., Waldeck K., Hannan K.M., Shortt J., Smyth M.J., Lowe Scott W., Hannan R.D., Pearson R.B., Johnstone R.W., McArthur G.A. The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence. Cancer Discov. 2013, 3:82-95.
103. Wang X., Campbell L., Miller C., Proud C. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 1998, 334:261-267.
104. West M.J., Stoneley M., Willis A.E. Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway. Oncogene 1998, 17:769-780.
105. Williamson D., Lu Y.J., Fang C., Pritchard-Jones K., Shipley J. Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma. Genes Chromosom. Cancer 2006, 45:839-845.
106. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 2010, 35:427-433.
107. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.-Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., McMahon S.B. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. 2008, 105:18782-18787.
108. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
109. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
110. Wu Z., Zha Z., Li G., Lieberman B.P., Choi S.R., Ploessl K., Kung H.F. [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine as a tumor imaging agent. Mol. Pharm. 2014, 10.1021/mp500236y.
111. Yang L., Song T., Chen L., Kabra N., Zheng H., Koomen J., Seto E., Chen J. Regulation of SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient availability. Mol. Cell. Biol. 2013, 33:3835-3848.
112. Yuan X., Zhao J., Zentgraf H., Hoffmann-Rohrer U., Grummt I. Multiple interactions between RNA polymerase I, TIF-IA and TAF(I) subunits regulate preinitiation complex assembly at the ribosomal gene promoter. EMBO Rep. 2002, 3:1082-1087.
113. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 2007, 178:93-105.
114. Yuneva M.O., Fan T.W., Allen T.D., Higashi R.M., Ferraris D.V., Tsukamoto T., Mates J.M., Alonso F.J., Wang C., Seo Y., Chen X., Bishop J.M. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 2012, 15:157-170.
115. Zhao J., Yuan X., Frödin M., Grummt I. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol. Cell 2003, 11:405-413.
116. Zhao Y., Butler E., Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 2013, 4:e532.
117. Zinzalla V., Hall M.N. Signal transduction: linking nutrients to growth. Nature 2008, 454:287-288.
118. +-ATPase. Science 2011, 334:678-683.